Alphamab Oncology (HKG:9966)
Hong Kong · Delayed Price · Currency is HKD 7.08
+0.02 (0.28%)
Oct 21, 2026, 2:55 PM HKT
Alphamab Oncology Market Cap
Alphamab Oncology has a market cap or net worth of 6.86 billion as of October 20, 2026. It is the 10,725th most valuable company in the world and the 526th biggest in Hong Kong. Its market cap has decreased by 47.93% in one year.
Market Cap
6.86B
Enterprise Value
5.51B
Revenue
598.06M
Global Rank
Country Rank
#526 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 6.86B, a decrease of -43.38%. That is a compound annual growth rate of -7.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.86B | -27.76% |
| Dec 31, 2025 | 9.49B | 181.80% |
| Dec 31, 2024 | 3.37B | -47.42% |
| Dec 29, 2023 | 6.41B | -36.87% |
| Dec 30, 2022 | 10.15B | -20.36% |
| Dec 31, 2021 | 12.74B | -16.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 8.63B |
| HBM Holdings | 8.56B |
| Nanjing Leads Biolabs | 8.06B |
| Shaanxi Micot Pharmaceutical Technology | 7.96B |
| CStone Pharmaceuticals | 7.91B |
| Shanghai Haohai Biological Technology | 7.18B |
| CARsgen Therapeutics Holdings | 6.56B |
| Lepu Biopharma | 6.35B |